Roches, PIASKY

Roche's PIASKY Approval for Paroxysmal Nocturnal Hemoglobinuria Treatment Will Give Tough Competition to AstraZeneca and Other Pharma Companies | DelveInsight

Published on 08/07/2025 at 18:05 | prnewswire.co.uk

DelveInsight Business Research, LLP United States of America United Kingdom


+14699457679

Logo: https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg 

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/roches-piasky-approval-for-paroxysmal-nocturnal-hemoglobinuria-treatment-will-give-tough-competition-to-astrazeneca-and-other-pharma-companies--delveinsight-302235684.html

en | GB0009895292 | ROCHES | boerse | 67970848 |